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Abstract The expression of uncoupling protein-2 (UCP2)
mRNA is up-regulated during the differentiation of brown
adipocytes in primary culture. When differentiation of brown
adipocytes is impaired, UCP2 mRNA expression is down-
regulated. 9-cis Retinoic acid causes a dose-dependent induction
of UCP2 mRNA levels in brown adipocytes, whereas all-trans
retinoic acid has no effect. Specific agonists of retinoid X
receptors (RXR) induce UCP2 mRNA expression, whereas
specific activators of retinoic acid receptors do not. 9-cis Retinoic
acid, acting through RXR receptors, is identified as a major
regulator of the expression of the UCP2 gene in the brown fat
cell.
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1. Introduction
Brown adipose tissue (BAT) is a major site for non-shiver-
ing thermogenesis in rodents either in response to cold or in
response to overfeeding [1]. It contains the uncoupling pro-
tein-1 (UCP1), a tissue-speci¢c mitochondrial protein that un-
couples oxidative phosphorylation and leads to the generation
of heat [2]. Until 1997, the various aspects of BAT thermo-
genic function were attributed to UCP1. The discovery of two
novel uncoupling protein genes, uncoupling protein-2 (UCP2)
and uncoupling protein-3, which are expressed in multiple
tissues including brown fat, opened new perspectives [3^6].
These proteins are considered to act as natural uncouplers
of oxidative phosphorylation, similarly to UCP1, and their
physiological role in mammalian thermogenesis is currently
under research. Several lines of evidence indicate that UCP2
expression may be involved in the brown fat thermogenesis
elicited by diet-dependent stimuli. Thus, genetic ablation of
BAT was reported to cause cold intolerance and impaired
diet-induced thermogenesis in mice [7]. However, targeted dis-
ruption of the UCP1 gene leads to cold-sensitive animals but
does not disturb the normal response to overfeeding [8], in
association with up-regulation of UCP2 gene expression in
brown fat. Moreover, obesity-prone strains of mice, such as
C57BL/6J, are characterized by low basal levels of UCP2 ex-
pression in several tissues including brown fat [3].
The mechanisms of regulation of UCP1 gene expression
have been widely studied and noradrenaline [9], retinoic acid
[10], thyroid hormones [11], insulin and insulin-like growth
factor 1 (IGF-1) [12] have been identi¢ed as regulators. How-
ever, little is known of the molecular signals that mediate
changes in UCP2 gene expression. Leptin has been reported
to in£uence UCP2 gene expression in several cell systems in-
cluding adipocytes [13]. Activators of peroxisome proliferator-
activated receptor (PPAR) Q have also been also reported to
up-regulate UCP2 mRNA levels in adipose cells [14]. Here we
have analyzed the regulation of expression of UCP2 in rela-
tion to brown adipocyte di¡erentiation and we have identi¢ed
9-cis retinoic acid (9-cis RA) as a major regulator of UCP2
gene expression in brown adipocytes.
2. Materials and methods
Noradrenaline, insulin, IGF-1, triiodothyronine (T3), LY171883,
all-trans retinoic acid (all-trans RA) and phytanic acid were from
Sigma (USA). Recombinant murine leptin was from PreProtech
(USA). WY 14,643 was and 15-deoxy-v-12,14-prostaglandin J2
(15d-PGJ2) were from Cayman (USA) and methoprene was from
Promochem (Germany). 9-cis RA, P-[(E)-2-(5,6,7,8-tetrahydro-
5,5,8,8,tetramethyl-2-naphthyl)-1-propenyl] benzoic acid (TTNPB)
and Am80 were kind gifts of Dr. I. Levine (Ho¡man-LaRoche,
USA), Dr. E.M. Gutknecht and Dr. P. Weber (Ho¡man-LaRoche,
Switzerland) and Dr. K. Shudo (University of Tokyo, Japan), respec-
tively.
Brown adipocytes were di¡erentiated in culture from precursor cells
as described previously [10]. Three-week-old Swiss mice were killed
and interscapular, cervical and axillar depots of BAT were removed.
Stromal vascular cells were isolated, plated (5000 cells/cm2) and
grown in Dulbecco’s modi¢ed Eagle’s medium:Ham’s F12 medium
(1:1, v/v) (DMEM/F12) supplemented with 10% (v/v) FCS, 20 nM
insulin, 2 nM T3 and 100 WM ascorbate. When indicated cells were
grown in a hormone-depleted non-di¡erentiating medium in which
DMEM/F12 was only supplemented with 10% (v/v) charcoal-treated
FCS [10]. The hormonal agonists were added to the regular culture
medium on day 9 and cells were harvested 24 h later with the excep-
tion of treatments with noradrenaline and 15-dPG-J2, which lasted
only 6 h. For exposure to insulin, IGF-1 and T3, regular culture
medium was replaced with the hormone-depleted medium.
RNA from BAT or brown adipocytes was extracted using a guani-
dine thiocyanate method [15]. 10 Wg of RNA was denatured, electro-
phoresed on 1.5% formaldehyde-agarose gels and transferred to pos-
itively charged membranes (N+, Boehringer Mannheim, Germany).
0.2 Wg of ethidium bromide was added to RNA samples to check
equal loading of gels and transfer e⁄ciency, as reported [16]. Prehy-
bridization and hybridization were performed as reported [17]. Blots
were hybridized using a mouse UCP2 probe obtained previously [18],
the rat cDNA for UCP1 [19] or the rat cDNA for subunit II of
cytochrome c oxidase (COII) [20]. The DNA probes were labeled by
the random oligonucleotide-primer method using [K-32P]dCTP. Hy-
bridization signals were quanti¢ed using a Molecular Image System
GS-525 (Bio-Rad). When indicated, statistical comparisons were car-
ried out using Student’s t-test.
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3. Results
3.1. Di¡erentiation-dependent regulation of UCP2 mRNA
expression in brown adipocytes
Fig. 1A shows the pro¢le of expression of UCP2 mRNA in
brown adipocytes di¡erentiating from stromal vascular cells
obtained from BAT depots of mice. In the conditions of cul-
ture used, precursor cells showed non-adipocyte morphology
on day 4, they reached con£uence and showed the ¢rst signals
of adipocyte di¡erentiation (accumulation of lipid droplets in
cells) on day 7, and they appeared fully di¡erentiated on day
10, when more than 90% of cells showed lipid accumulation.
UCP2 mRNA was induced from day 4 (non-di¡erentiated
cells) to day 7 (early di¡erentiated cells) of culture, whereas
it declined thereafter (day 10, late di¡erentiated cells). When
compared with UCP1 mRNA, UCP2 mRNA expression fol-
lowed an earlier pro¢le of induction. Thus, whereas maximal
induction of UCP1 mRNA was observed in terminally di¡er-
entiated brown adipocytes (day 10), the highest UCP2 mRNA
levels were attained earlier, at the beginning of the di¡erentia-
tion process (day 7). The pro¢le of expression of UCP2
mRNA was much more similar to the pattern of induction
of COII mRNA, a molecular marker of mitochondrial bio-
genesis. When precursor cells were cultured for 10 days in a
hormone-depleted medium, adipocyte di¡erentiation was
blunted and UCP2 mRNA expression was not induced as
observed for UCP1 mRNA or COII mRNA (see Fig. 1B).
On the other hand, and in contrast to UCP1 mRNA levels,
which are lower in brown adipocytes than in BAT, UCP2
mRNA abundance in di¡erentiated brown adipocytes was
even higher than that present in the tissue.
3.2. E¡ects of hormonal agonists on UCP2 mRNA expression
in di¡erentiated brown adipocytes: 9-cis RA is a major
activator of UCP2 gene expression
Di¡erent hormonal agents that are known to in£uence
brown adipocyte thermogenic function or UCP1 gene expres-
sion were tested to assess their potential involvement in the
regulation of the UCP2 gene. Densitometry analysis of the
changes in UCP2 mRNA levels caused by these agents is
FEBS 21345 30-12-98
Fig. 1. Changes in the expression of UCP2 mRNA during brown adipocyte di¡erentiation in primary culture. RNA (10 Wg) was extracted from
cells or tissue and analyzed by Northern blot. A: Points are means of two samples each one from triplicate plates and di¡ering less than 15%
for each stage of culture of stromal vascular cells. Data are expressed as percentages relative to the mean value at the developmental time of
maximum levels of expression which was set at 100 (arbitrary units). B: Representative Northern blot analysis of equal amounts of RNA (10
Wg/lane) from interscapular BAT (BAT), brown adipocytes di¡erentiated in culture (D) (day 10) or cells in which di¡erentiation was blocked
(ND) (day 10) because of replacement of regular culture medium with depleted medium (see Section 2 for details).
Table 1
E¡ects of hormonal agonists on UCP2 mRNA levels in brown adi-
pocytes in culture
Agonist Fold induction of UCP2
mRNA levels
Noradrenaline 1.8 þ 0.4
Insulin 1.5 þ 0.2
IGF-1 1.6 þ 0.4
T3 1.3 þ 0.3
Leptin 2.2 þ 0.2*
PPAR agonists
LY171883 3.1 þ 0.4*
WY 14,643 10 WM 1.2 þ 0.2
WY 14,643 100 WM 3.4 þ 0.5*
15dPGJ2 2.1 þ 0.2*
All-trans RA 1.6 þ 0.4
9-cis RA 4.4 þ 0.3**
Di¡erentiated brown adipocytes (day 9 of culture) were exposed to 10
nM insulin, 10 nM IGF-1, 2 nM T3, 30 nM leptin, 30 WM LY171883,
10 WM or 100 WM WY 14,643, 1 WM all-trans RA or 1 WM 9-cis RA
for 24 h or to 0.5 WM noradrenaline or 10 WM 15d-PGJ2 for 6 h.
Changes in UCP2 mRNA levels, expressed as fold induction with
respect to untreated controls, are shown as means þ S.E.M. of at least
three independent experiments. Statistically signi¢cant di¡erences:
*P6 0.05, **P6 0.01.
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shown in Table 1. Neither norepinephrine, insulin, IGF-1 nor
T3 signi¢cantly modi¢ed UCP2 mRNA levels in brown adi-
pocytes. Leptin caused a modest but signi¢cant increase.
Treatment of cells with several agonists of PPAR had signi¢-
cant e¡ects. LY171883 or 100 WM WY 14,643, non-subtype-
speci¢c PPAR activators [21,22], caused a signi¢cant induc-
tion of UCP2 mRNA levels, whereas 10 WM WY 14,643, a
concentration speci¢c for PPARK activation [21], had no ef-
fect. 15d-PGJ2, a natural agonist of PPARQ [23], caused a
modest but signi¢cant induction. Retinoids had very di¡erent
e¡ects: whereas all-trans RA did not a¡ect UCP2 mRNA
levels, 9-cis RA caused a marked increase and led to the high-
est e¡ect on UCP2 gene expression in brown adipocytes.
Dose-response e¡ects of 9-cis RA on UCP2 mRNA expres-
sion are depicted in Fig. 2 and show a maximum of activation
when brown adipocytes were exposed to 1 WM 9-cis RA,
similarly to other previously characterized target genes for
9-cis RA action [24].
3.3. E¡ects of retinoic acid receptor (RAR)- and retinoid X
receptor (RXR)-speci¢c agonists on UCP2 mRNA
expression in brown adipocytes
To assess the involvement of the two potential receptors of
9-cis RA action, brown adipocytes were exposed to either
synthetic retinoids or naturally occurring substances speci¢c
for RAR or RXR. Treatment of brown adipocytes with
TTNPB or Am80, speci¢c for RAR [25,26], did not a¡ect
UCP2 mRNA levels (Table 2). In contrast, synthetic (metho-
prene) [27] or naturally occurring (phytanic acid) [28] speci¢c
activators of RXR caused signi¢cant rises in UCP2 mRNA
abundance.
4. Discussion
The expression of the UCP2 gene shows a di¡erentiation-
dependent regulation in the brown fat cell. The pro¢le of
expression of the UCP2 gene in di¡erentiating brown adipo-
cytes is clearly dissociated from the pattern of induction of
UCP1 gene expression, as the maximal induction of UCP2
gene expression occurs earlier than maximal UCP1 mRNA
expression. However, the expression of the UCP2 gene ap-
pears to be a component of the di¡erentiated phenotype of
the brown adipocyte, as cells that were not allowed to di¡er-
entiate showed minimum levels of UCP2 gene expression. The
parallelism between UCP2 mRNA and COII mRNA pro¢les
of induction strongly suggests that the UCP2 gene may be
regulated in coordination with the mitochondrial biogenesis
that occurs during the di¡erentiation of the brown adipocyte
[29]. Similar conclusions have been reached in previous studies
on UCP2 mRNA expression during brown fat prenatal on-
togeny [18]. Moreover, the ¢nding that, in contrast to UCP1
mRNA, UCP2 mRNA is not down-regulated in cultured cells
with respect to the tissue further indicates a di¡erential regu-
lation of the two genes.
The di¡erential regulation of the UCP2 gene was further
established by the analysis of sensitivity of its expression to
hormonal stimuli. Powerful activators of UCP1 gene expres-
sion such as noradrenaline, insulin or IGF-1 had no e¡ect on
UCP2. The present data on lack of stimulus of UCP2 gene
expression by noradrenaline are consistent with data in vivo,
in which treatment with L-adrenergic agents did not a¡ect
UCP2 mRNA expression in brown fat [30]. Moreover, leptin
caused a signi¢cant but modest increase in UCP2 mRNA
levels consistent with previous ¢ndings in other cell systems
[13]. Activators of PPAR also caused a rise in UCP2 mRNA
levels, but only when PPARQ was activated. This indicates
that this subtype of PPAR is involved in UCP2 gene regula-
tion, whereas the PPARK subtype is not, even though it is
highly expressed in the brown fat cell. However, of all the
agents tested, 9-cis RA acid was capable of the highest induc-
tion of UCP2 gene expression in brown adipocytes.
In 1995, all-trans RA was reported to be a powerful inducer
of UCP1 gene expression [10], and activation of RAR and
RXR receptors was described to mediate this e¡ect [10,31].
The present study identi¢es another retinoid, 9-cis RA, as a
major regulator of the expression of UCP2. Retinoids a¡ect
gene expression through the activation of RAR or RXR re-
ceptors that act as ligand-dependent transcription factors. All-
trans RA activates RAR receptors when they heterodimerize
with RXR. In contrast, 9-cis RA can activate RAR but also
RXR when it forms homodimers or heterodimers with other
members of the nuclear receptor superfamily [32]. The fact
that 9-cis RA was a strong activator of UCP2 while all-trans
RA was not suggests that RXR is the receptor mediating the
9-cis RA e¡ect and that RAR is not involved in the regulation
of UCP2 gene expression. This was con¢rmed by the use of
non-isomerizable, speci¢c agonists of RAR and RXR. The
lack of e¡ect of all-trans RA on UCP2 may be due to the
characteristics of the UCP2 gene regulatory region, since dif-
ferentiated brown adipocytes express RAR as well as RXR
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Table 2
E¡ects of RAR-speci¢c or RXR-speci¢c agonists on UCP2 mRNA
levels in brown adipocytes in culture
Agonist Fold induction of UCP2
mRNA levels
RAR-speci¢c
TTNPB 1.2 þ 0.3
Am80 0.9 þ 0.1
RXR-speci¢c
Methoprene 2.9 þ 0.4*
Phytanic acid 3.1 þ 0.4*
Di¡erentiated brown adipocytes (day 9 of culture) were exposed for
24 h to 10 WM TTNPB, 10 WM Am80, 100 WM methoprene or 20 WM
phytanic acid. Changes in UCP2 mRNA levels, expressed as fold
induction with respect to untreated controls, are shown as means
þ S.E.M. of at least three independent experiments. Statistically sig-
ni¢cant di¡erences: *P6 0.05.
Fig. 2. Dose-response curve for the e¡ect of 9-cis RA on UCP2
mRNA expression. Brown adipocytes di¡erentiated in culture from
stromal vascular cells (day 9) were exposed to the indicated concen-
trations of 9-cis RA for 24 h. Points are means from at least two
independent experiments with triplicate plates.
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[31]. On the other hand, the fact that activation of RXR
induces UCP2 gene expression and that PPAR activators
are also positive e¡ectors suggests that UCP2 gene may be
under the control of transcription factors composed of heter-
odimers of PPAR and RXR. Several genes have been reported
to be regulated by these heterodimers in which both partners,
PPAR and RXR, retain the sensitivity to activation by their
respective ligands [33]. However, the presence of RXR homo-
dimer-dependent gene regulatory elements in the UCP2 gene,
irrespective of the presence of PPAR-dependent regulatory
elements, cannot be ruled out. Only the analysis of the
UCP2 gene regulatory region will allow the identi¢cation of
the precise molecular mechanisms by which 9-cis RA induces
the transcription of this gene.
Retinoids exert powerful e¡ects on di¡erentiation and gene
expression in adipose tissues [34]. The strong stimulatory ac-
tion of 9-cis RA on UCP2 gene expression, together with
previous ¢ndings on up-regulation of the UCP1 gene by all-
trans RA, indicates that vitamin A derivatives may in£uence
energy expenditure in mammals and opens new potential
strategies in the development of molecules for the treatment
of body weight disturbances.
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